Status: Recruiting
Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke
The primary objective of this study is to further define the mechanisms of action of Mexidol® (solution for intravenous and intramuscular injection, 50 mg/ml) and Mexidol® FORTE 250 (film-coated tablets, 250 mg) in the hyperacute and acute periods of ischemic stroke, and to evaluate their impact on clinical and neuroimaging outcomes of the disease.
Participants needed: 120
Trial details
Phase: Phase 4Age: 18-90Biological sex: AllType: InterventionalSponsor: PharmasoftUpdated: May 13, 2026Locations: 9
Eligibility criteria
Signed and dated Informed Consent Form (ICF) by the patient or their legal repre... [+13]
Hypersensitivity to ethylmethylhydroxypyridine succinate or any other components... [+77]